Skip to main content
. Author manuscript; available in PMC: 2015 Jul 3.
Published in final edited form as: Oncogene. 2013 Aug 12;33(27):3485–3495. doi: 10.1038/onc.2013.302

Figure 3. TLR agonists for clinical anti-tumor therapies.

Figure 3

A. Summary of trials from ClinicalTrial.gov employing TLR agonists or TLR-agonistic Bacillus Calmette-Guérin (BC). B. List of FDA-approved TLR agonists for tumor therapy (upper section) and TLR agonists currently being evaluated for tumor therapy (lower section), including the National Clinical Trial (NCT) number from ClinicalTrials.gov.